ATE534392T1 - Verwendung eines neuen therapeutikums zur behandlung von leukämie - Google Patents

Verwendung eines neuen therapeutikums zur behandlung von leukämie

Info

Publication number: ATE534392T1
Authority: AT; Austria
Prior art keywords: new therapeutic; treat leukemia; leukemia; treat; therapeutic
Prior art date: 2006-12-28

Application number

AT07872446T

Other languages

English (en)

Inventor

Bernard Bourrie

Pierre Casellas

Original Assignee

Sanofi Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-12-28

Filing date

2007-12-27

Publication date

2011-12-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38268928&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE534392(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-12-27 Application filed by Sanofi Sa filed Critical Sanofi Sa

2011-12-15 Application granted granted Critical

2011-12-15 Publication of ATE534392T1 publication Critical patent/ATE534392T1/de

Links

208000032839 leukemia Diseases 0.000 title 1
230000001225 therapeutic effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Hematology (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

AT07872446T 2006-12-28 2007-12-27 Verwendung eines neuen therapeutikums zur behandlung von leukämie ATE534392T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0611492A FR2910813B1 (fr)	2006-12-28	2006-12-28	Nouvelle utilisation therapeutique pour le traitement des leucemies
PCT/FR2007/002171 WO2008102075A2 (fr)	2006-12-28	2007-12-27	Nouvelle utilisation therapeutique pour le traitement des leucemies

Publications (1)

Publication Number	Publication Date
ATE534392T1 true ATE534392T1 (de)	2011-12-15

Family

ID=38268928

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT07872446T ATE534392T1 (de)	2006-12-28	2007-12-27	Verwendung eines neuen therapeutikums zur behandlung von leukämie

Country Status (39)

Country	Link
US (1)	US8236811B2 (de)
EP (1)	EP2107906B1 (de)
JP (1)	JP5317987B2 (de)
KR (1)	KR101458233B1 (de)
CN (1)	CN101568338B (de)
AR (1)	AR064550A1 (de)
AT (1)	ATE534392T1 (de)
AU (1)	AU2007347370B2 (de)
BR (1)	BRPI0720963A2 (de)
CA (1)	CA2672716C (de)
CL (1)	CL2007003846A1 (de)
CO (1)	CO6190610A2 (de)
CR (1)	CR10881A (de)
CY (1)	CY1112443T1 (de)
DK (1)	DK2107906T3 (de)
EA (1)	EA016873B1 (de)
EC (1)	ECSP099449A (de)
ES (1)	ES2377843T3 (de)
FR (1)	FR2910813B1 (de)
GT (1)	GT200900168A (de)
HR (1)	HRP20120170T1 (de)
JO (1)	JO2748B1 (de)
MA (1)	MA31100B1 (de)
MX (1)	MX2009007054A (de)
MY (1)	MY148515A (de)
NI (1)	NI200900129A (de)
NO (1)	NO20092496L (de)
NZ (1)	NZ577991A (de)
PE (1)	PE20081548A1 (de)
PL (1)	PL2107906T3 (de)
PT (1)	PT2107906E (de)
RS (1)	RS52162B (de)
SI (1)	SI2107906T1 (de)
SV (1)	SV2009003315A (de)
TN (1)	TN2009000234A1 (de)
TW (1)	TWI433678B (de)
UA (1)	UA97505C2 (de)
WO (1)	WO2008102075A2 (de)
ZA (1)	ZA200904478B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2948568B1 (fr) *	2009-07-30	2012-08-24	Sanofi Aventis	Formulation pharmaceutique
EP2638911A1 (de) *	2012-03-14	2013-09-18	Sanofi	Neuartige Kombinationen zur Behandlung von akuter myeloischer Leukämie oder chronischer myeloischer Leukämie
CN105813635A (zh) *	2013-12-13	2016-07-27	诺华股份有限公司	药物剂型
WO2021061874A2 (en) *	2019-09-23	2021-04-01	President And Fellows Of Harvard College	Methods and compositions for treating acute myeloid leukemia

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1171218A (en)	1967-11-09	1969-11-19	Parke Davis & Co	New Heterocyclic Amine Compounds and Methods for their Production
IL115256A0 (en)	1994-11-14	1995-12-31	Warner Lambert Co	6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use
MX9702245A (es)	1994-11-14	1997-06-28	Warner Lambert Co	Seis-aril-pirido(2,3-d)pirimidinas y naftiridinas para inhibir la proliferacion celular mediada por la proteina cinasa tirosina.
IL117923A (en)	1995-05-03	2000-06-01	Warner Lambert Co	Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
US5620981A (en)	1995-05-03	1997-04-15	Warner-Lambert Company	Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation
US7115750B1 (en)	1999-09-20	2006-10-03	Takeda Pharmaceutical Company Limited	Melanin concentrating hormone antagonist
WO2001055147A1 (en) *	2000-01-25	2001-08-02	Warner-Lambert Company	PYRIDO[2,3-d]PYRIMIDINE-2,7-DIAMINE KINASE INHIBITORS
EE200200506A (et)	2000-03-06	2004-02-16	Warner-Lambert Company	5-alküülpürido[2,3-d]pürimidiinid kui türosiinkinaasi inhibiitorid
JP2004519422A (ja)	2000-08-04	2004-07-02	ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー	２−（４−ピリジル）アミノ−６−ジアルコキシフェニルピリド〔２，３−ｄ〕ピリミジン−７−オン
AU2002324450A1 (en) *	2001-06-21	2003-01-08	Ariad Pharmaceuticals, Inc.	Novel pyridopyrimidines and uses thereof
WO2004063195A1 (en)	2003-01-03	2004-07-29	Sloan-Kettering Institute For Cancer Research	Pyridopyrimidine kinase inhibitors
TW200502236A (en)	2003-03-28	2005-01-16	Hoffmann La Roche	Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
WO2005105097A2 (en)	2004-04-28	2005-11-10	Gpc Biotech Ag	Pyridopyrimidines for treating inflammatory and other diseases
FR2873118B1 (fr)	2004-07-15	2007-11-23	Sanofi Synthelabo	Derives de pyrido-pyrimidine, leur application en therapeutique
UY29017A1 (es)	2004-07-16	2006-02-24	Boehringer Ingelheim Int	Inhibidores de polimerasa viral
FR2887882B1 (fr) *	2005-07-01	2007-09-07	Sanofi Aventis Sa	Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
FR2896246B1 (fr)	2006-01-13	2008-08-15	Sanofi Aventis Sa	Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique.

2006
- 2006-12-28 FR FR0611492A patent/FR2910813B1/fr not_active Expired - Fee Related
2007
- 2007-12-24 TW TW096149811A patent/TWI433678B/zh not_active IP Right Cessation
- 2007-12-27 JP JP2009543501A patent/JP5317987B2/ja not_active Expired - Fee Related
- 2007-12-27 CN CN2007800482286A patent/CN101568338B/zh not_active Expired - Fee Related
- 2007-12-27 ZA ZA200904478A patent/ZA200904478B/xx unknown
- 2007-12-27 RS RS20120061A patent/RS52162B/sr unknown
- 2007-12-27 PL PL07872446T patent/PL2107906T3/pl unknown
- 2007-12-27 AT AT07872446T patent/ATE534392T1/de active
- 2007-12-27 KR KR1020097013456A patent/KR101458233B1/ko not_active Expired - Fee Related
- 2007-12-27 NZ NZ577991A patent/NZ577991A/en not_active IP Right Cessation
- 2007-12-27 UA UAA200907941A patent/UA97505C2/ru unknown
- 2007-12-27 DK DK07872446.5T patent/DK2107906T3/da active
- 2007-12-27 AU AU2007347370A patent/AU2007347370B2/en not_active Ceased
- 2007-12-27 WO PCT/FR2007/002171 patent/WO2008102075A2/fr not_active Ceased
- 2007-12-27 BR BRPI0720963-0A patent/BRPI0720963A2/pt active Search and Examination
- 2007-12-27 CA CA2672716A patent/CA2672716C/fr not_active Expired - Fee Related
- 2007-12-27 MY MYPI20092747A patent/MY148515A/en unknown
- 2007-12-27 JO JO2007563A patent/JO2748B1/en active
- 2007-12-27 HR HR20120170T patent/HRP20120170T1/hr unknown
- 2007-12-27 ES ES07872446T patent/ES2377843T3/es active Active
- 2007-12-27 CL CL2007003846A patent/CL2007003846A1/es unknown
- 2007-12-27 PT PT07872446T patent/PT2107906E/pt unknown
- 2007-12-27 SI SI200730860T patent/SI2107906T1/sl unknown
- 2007-12-27 AR ARP070105919A patent/AR064550A1/es not_active Application Discontinuation
- 2007-12-27 EP EP07872446A patent/EP2107906B1/de active Active
- 2007-12-27 MX MX2009007054A patent/MX2009007054A/es active IP Right Grant
- 2007-12-27 EA EA200970639A patent/EA016873B1/ru not_active IP Right Cessation
2008
- 2008-01-02 PE PE2008000043A patent/PE20081548A1/es not_active Application Discontinuation
2009
- 2009-06-08 TN TNP2009000234A patent/TN2009000234A1/fr unknown
- 2009-06-16 US US12/485,401 patent/US8236811B2/en not_active Expired - Fee Related
- 2009-06-16 GT GT200900168A patent/GT200900168A/es unknown
- 2009-06-22 CR CR10881A patent/CR10881A/es not_active Application Discontinuation
- 2009-06-22 EC EC2009009449A patent/ECSP099449A/es unknown
- 2009-06-24 SV SV2009003315A patent/SV2009003315A/es active IP Right Grant
- 2009-06-26 CO CO09066898A patent/CO6190610A2/es active IP Right Grant
- 2009-06-26 NI NI200900129A patent/NI200900129A/es unknown
- 2009-07-02 NO NO20092496A patent/NO20092496L/no not_active Application Discontinuation
- 2009-07-16 MA MA32101A patent/MA31100B1/fr unknown
2012
- 2012-02-23 CY CY20121100183T patent/CY1112443T1/el unknown

Also Published As

Publication number	Publication date
AR064550A1 (es)	2009-04-08
PL2107906T3 (pl)	2012-04-30
GT200900168A (es)	2010-03-19
NZ577991A (en)	2012-01-12
JO2748B1 (en)	2014-03-15
BRPI0720963A2 (pt)	2014-03-18
MA31100B1 (fr)	2010-01-04
FR2910813A1 (fr)	2008-07-04
DK2107906T3 (da)	2012-03-19
JP2010514743A (ja)	2010-05-06
CA2672716C (fr)	2013-05-28
NI200900129A (es)	2011-12-13
ZA200904478B (en)	2010-08-25
CL2007003846A1 (es)	2009-01-23
EA016873B1 (ru)	2012-08-30
CN101568338B (zh)	2011-11-23
TWI433678B (zh)	2014-04-11
US8236811B2 (en)	2012-08-07
TN2009000234A1 (fr)	2010-10-18
WO2008102075A3 (fr)	2008-12-11
MY148515A (en)	2013-04-30
CY1112443T1 (el)	2015-12-09
SV2009003315A (es)	2010-02-05
SI2107906T1 (sl)	2012-03-30
TW200833343A (en)	2008-08-16
RS52162B (sr)	2012-08-31
PT2107906E (pt)	2012-03-05
CN101568338A (zh)	2009-10-28
EP2107906A2 (de)	2009-10-14
JP5317987B2 (ja)	2013-10-16
CA2672716A1 (fr)	2008-08-28
NO20092496L (no)	2009-07-23
AU2007347370B2 (en)	2013-05-23
PE20081548A1 (es)	2009-01-04
UA97505C2 (ru)	2012-02-27
HK1138189A1 (en)	2010-08-20
KR101458233B1 (ko)	2014-11-04
CR10881A (es)	2009-08-12
KR20090103899A (ko)	2009-10-01
US20090298790A1 (en)	2009-12-03
HRP20120170T1 (hr)	2012-03-31
EP2107906B1 (de)	2011-11-23
ES2377843T3 (es)	2012-04-02
FR2910813B1 (fr)	2009-02-06
MX2009007054A (es)	2009-08-12
EA200970639A1 (ru)	2010-04-30
WO2008102075A2 (fr)	2008-08-28
CO6190610A2 (es)	2010-08-19
AU2007347370A1 (en)	2008-08-28
ECSP099449A (es)	2009-07-31

Publication	Publication Date	Title
ATE534379T1 (de)	2011-12-15	Neue verwendung von peptid-verbindungen zur behandlung von muskelschmerzen
ATE434620T1 (de)	2009-07-15	Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
ATE534633T1 (de)	2011-12-15	Indazolderivate zur behandlung von hsp90- induzierten krankheiten
EP2182983A4 (de)	2011-03-02	Behandlung von amyloidogenen erkrankungen
DE602006019838D1 (de)	2011-03-10	Piperazinsubstituierte benzothiophene zur behandlung von geisteskrankheiten
EP3861968C0 (de)	2023-09-06	Vorrichtungen zur behandlung von schlafapnoe
ATE521352T1 (de)	2011-09-15	Verwendung von flibanserin zur behandlung von prämenopausalen störungen der sexuellen lust
EP3868323C0 (de)	2023-09-06	Minimalinvasive vorrichtungen zur behandlung von prostataerkrankungen
DE602007011052D1 (de)	2011-01-20	Behandlung von mineralschlämmen mit verbesserter pflanzenwachstumsrehabilitation
EP2135858A4 (de)	2012-02-08	Zusammensetzung zur behandlung von infektionserkrankungen
CO6300844A2 (es)	2011-07-21	Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasa
DE602005007717D1 (de)	2008-08-07	Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen
EP2579936A4 (de)	2015-04-15	Magensonde zur behandlung von adipositas
DE602005017636D1 (de)	2009-12-24	Neue hydantoinderivate zur behandlung von obstruktiven atemwegserkrankungen
ATE509621T1 (de)	2011-06-15	Verwendung von 2,5-dihydroxybenzolderivaten zur behandlung von arthritis und schmerzen
DE602007008494D1 (de)	2010-09-30	Verwendung von Agomelatin zur Herstellung von Medikamenten zur Behandlung der generalisierten Angststörung
ATE476414T1 (de)	2010-08-15	Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen
ATE447551T1 (de)	2009-11-15	Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
ATE438623T1 (de)	2009-08-15	Aroyl-o-piperidinderivate zur behandlung von problemen im zusammenhang mit diabetes
EP2249765A4 (de)	2012-09-05	Dapson zur behandlung von rosascea
FI20095600L (fi)	2009-06-09	Koostumus ihosairauksien hoitoa varten
DE602007009877D1 (de)	2010-11-25	Isosorbid-mononitrat-derivate zur behandlung von darmerkrankungen
ATE446092T1 (de)	2009-11-15	Verwendung von oxycodon zur behandlung von viszeralem schmerz
ATE537178T1 (de)	2011-12-15	Neue klasse von spiro-piperidinen zur behandlung neurodegenerativer krankheiten
ATE482709T1 (de)	2010-10-15	Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen